Using the tools of nanotechnology and synthetic biology

Combating infectious diseases and cancer

Developing a new class of vaccines and immunotherapeutic drugs


Virometix closes extension financing round

Zurich, Switzerland (November 19, 2014) – Virometix today announced that it has closed an extension to its recent financing round. Virometix will use the proceeds to further speed up the development of its vaccine candidates for infectious and viral diseases.

Virometix moves to a new location

Zurich-Schlieren, Switzerland (July 21, 2014) – Virometix today announced relocation of its operations to new premises in order to better meet the business needs of the company. The new office is located at the BIO-TECHNOPARK Zurich–Schlieren, which hosts a cluster of life science companies ranging from recent University spin-offs to leading global pharmaceutical companies.

More News

Events & Presentations

Vaccines R&D 2015

November 02–04, Doubletree Baltimore BWI Airport, Baltimore, USA - Presentation by Dr. Armando Zuniga.

A3P International Biomanufacturing Congress

May 26-27, 2015, SwissTech Convention Center, Lausanne, Switzerland - Presentation by Dr. Armando Zuniga.

2014 Vaccines, Immunotherapy and Cell Therapies Congress

December 3-4, 2014, Sheraton Brussels Hotel, Brussels, Belgium - Presentation by Dr. Arin Ghasparian.

More Events & Presentations